# ISARIC4C {start: 2020-03-15}

- Co-Infection with influenza virus is associated with worse outcomes in hospitalised Covid patients [https://doi.org/10.1016/S0140-6736(22)00383-X]
- Sharing samples and data
- Impacting Policy
- Risk prediction: the 4C Mortality Score [https://doi.org/10.1136/bmj.m3339]
- Characterisation of hospitalised cases of COVID-19 [https://doi.org/10.1136/bmj.m1985]
- Genetic mechanisms of severe Covid-19 [https://doi.org/10.1038/s41586-020-03065-y]
- Clinical characterisation of Covid-19 in children [https://doi.org/10.1136/bmj.m3249]
- Characterisation of in-hospital complications associated with COVID-19 [https://doi.org/10.1016/S0140-6736(21)00799-6]
- Circulating histones play a central role in COVID-19-associated coagulopathy and mortality [https://doi.org/10.3324/haematol.2021.278492]
- Tissue proteomic analysis identifies mechanisms and stages of immunopathology in fatal COVID-19 [https://doi.org/10.1165/rcmb.2021-0358OC]
- Hospital acquired COVID-19 in England during the first wave of the pandemic [https://doi.org/10.1186/s12879-022-07490-4]
- Long Covid in adults discharged from UK hospitals after Covid-19 [https://doi.org/10.1101/2021.03.18.21253888]
- Treating COVID-19 patients with dexamethasone and remdesivir prevents neurological complications [https://doi.org/10.1002/ana.26536]
- UK Paediatric COVID-19 cases in the first and second pandemic wave [https://doi.org/10.1038/s41390-022-02052-5]
- Vitamin D insufficiency in COVID-19 and influenza A [http://dx.doi.org/10.1136/bmjopen-2021-055435]
- Using a double binding antigen assay to detect and measure SARS-CoV-2 antibodies [https://doi.org/10.1016/j.jviromet.2022.114475]
- Detecting SARS-CoV-2 by non-invasive means [https://doi.org/10.1016/j.jinf.2022.05.033]
- Understanding the Omicron variant and how it responds to vaccination [https://doi.org/10.1016/j.cell.2022.06.005]
- Evaluation of effectiveness of remdesivir in treating severe COVID-19 [https://doi.org/10.1101/2021.06.18.21259072]
- WHO guidelines on the use of chest imaging in COVID-19 [https://apps.who.int/iris/handle/10665/361833]
- Distinct clinical symptom patterns in patients hospitalised with COVID-19 [https://doi.org/10.1038/s41598-022-08032-3]
- Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 [https://doi.org/10.1016/S2665-9913(21)00104-1]
- Role of blood cytokines IL-6 and GM-CSF in severe COVID-19 [https://doi.org/10.1126/sciimmunol.abg9873]
- T cells target many different parts of the virus [https://doi.org/10.1038/s41590-020-0782-6]
- Setting Serology Standards
- Viral spike variants evading antibody-mediated immunity [https://doi.org/10.1016/j.cell.2021.01.037]
- SARS-CoV-2 surface and air contamination in a healthcare setting [https://doi.org/10.1093/cid/ciaa905]
- Impact of ethnicity [http://dx.doi.org/10.2139/ssrn.3618215]
- Supporting vaccine development [https://doi.org/10.1016/S0140-6736(20)31604-4]
- ICECAP autopsy study [https://doi.org/10.1164/rccm.202008-3265OC]
- Viral RNA found in blood is not infectious [https://doi.org/10.12688/wellcomeopenres.16002.1]
- Developing methods of sequencing the virus [http://doi.org/10.3390/v12101164]
- Adverse outcomes in COVID-19 patients with underlying respiratory conditions [https://doi.org/10.1016/s2213-2600(21)00013-8]
- Pulmonary Microthrombosis and Vasculitis in Life-Threatening Respiratory Virus Diseases [http://doi.org/10.1093/ofid/ofaa640]
- Using imaging in COVID-19 -- UK National COVID-19 Chest Imaging Database [http://doi.org/10.1183/13993003.01809-2020]
- Outcomes of hospitalised COVID-19 patients with interstitial lung disease [https://doi.org/10.1164/rccm.202007-2794oc]
- Outcomes of COVID-19 hospitalisation among patients with HIV [https://doi.org/10.1093/cid/ciaa1605]
- Co-Infections, Secondary Infections, and Antimicrobial Usage [https://doi.org/10.1016/S2666-5247(21)00090-2]
- Testing the tests [https://doi.org/10.12688/wellcomeopenres.15927.1]
- COVID-19 and Cancer [http://doi.org/10.1136/esmoopen-2020-000825]
- Detection of antibodies to determine population exposure [https://doi.org/10.2807/1560-7917.ES.2020.25.42.2000685]
- Symptom clusters [https://doi.org/10.1101/2020.08.14.20168088]
- New immune biomarkers for COVID-19 [https://doi.org/10.1111/imm.13585]
- Vulnerability of Down's syndrome (DS) patients to severe COVID-19 [https://doi.org/10.1016/j.eclinm.2021.100769]
- Modelling the association of tiered restrictions with COVID-19 deaths and hospital admissions [https://doi.org/10.1016/s1473-3099(20)30984-1]
- ISARIC4C within the global ISARIC-network
- Multi-model forecasts to inform the response to COVID-19 in the UK [https://doi.org/10.1101/2020.11.11.20220962]
- Remdesivir Statistical Analysis Plan
